Cathie Wood's position in Beam Therapeutics is currently worth $273 Million. That's 1.87% of their equity portfolio (18th largest holding). The investor owns 11.04% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares seven more times and sold shares on two occasions. The investor's estimated purchase price is $679 Million, resulting in a loss of 60%.